Despite treating older, sicker patients and performing more non-elective surgeries, osteopathic surgeons achieved comparable 30-day mortality rates to their allopathic counterparts, with no significant differences in readmissions or length of stay.
A systematic analysis of 68 studies and 9,525 participants with schizophrenia spectrum disorders found that no antipsychotic significantly outperformed placebo in improving cognitive function. The analysis concludes that standardizing cognitive assessments in clinical trials could enhance result consistency. (Source: JAMA Psychiatry)
New study: Maternal COVID-19 exposure in utero not linked to increased risk of neurodevelopmental delays in children through 24 months. Read more in JAMA Network Open.
A recent study in JAMA Internal Medicine revealed that acupuncture significantly reduced chronic sciatica pain compared to sham acupuncture, with lasting benefits of up to 52 weeks.
FDA approves Avadel Pharmaceuticals' once-nightly dosing sleep disorder drug, Lumryz, for children aged 7 years and older, offering a new option for narcolepsy treatment.
A recent study in JAMA Health Forum found that patients treated by altruistic physicians had lower healthcare spending and were less likely to experience preventable hospital admissions and emergency department visits.